Stockreport

Relay Therapeutics Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF Net loss: US$342.0m (loss widened by 18% from FY 2022). US$2.79 loss per share (further deteriorated from US$2.59 loss in FY 2022). All figures shown in the chart a [Read more]